Axon Therapy® bridges technology and neurology to deliver a first-of-its-kind, FDA-cleared, non-opioid front-line treatment for chronic post-trauma and post-surgical pain.
Axon Therapy non-invasively delivers focused magnetic pulses through a figure-8-shaped coil, targeting the damaged A-Beta sensory nerve fibers, proximal to the neuroma. By activating A-Beta, Axon Therapy helps modulate pain fiber activity at the site of trauma. The annual treatment protocol includes 16, 15-minute treatments. By month three, patients are able to sustain up to 30 days of durability with greater than 50% pain relief between monthly treatments.
Pain patients have notoriously been left behind when it comes to medical innovation. Legacy therapies for patients with trauma-induced neuropathic pain have included only off-label surgical and pharmaceutical treatment options that temporarily mask the pain signal or “numb” the pain. This has left physicians frustratingly — and often heart-breakingly — unable to offer patients interventions that provide quality-of-life improving relief.
We sought to create Axon Therapy as the first on-label solution to address the root cause of post-trauma and post-surgical neuropathic pain and provide durable relief. Our goal is to empower physicians with alternatives for managing pain that aren’t opioids, and a means to provide patients they currently may not be able to support with immediate, significant and sustainable pain reduction and a renewed sense of hope.
We believe that Axon Therapy is the best treatment for nerve pain. But don’t take our word for it. Hear from these patients who have undergone our cutting-edge treatment, and are now thriving: